[Tachycardia and pulmonary arterial hypertension].
Tachykardien bei pulmonalarterieller Hypertonie.
Clinical relevance
PH
Pathophysiology
Supraventricular arrhythmias
Therapy
Journal
Herzschrittmachertherapie & Elektrophysiologie
ISSN: 1435-1544
Titre abrégé: Herzschrittmacherther Elektrophysiol
Pays: Germany
ID NLM: 9425873
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
07
12
2019
accepted:
13
01
2020
pubmed:
13
2
2020
medline:
4
3
2020
entrez:
13
2
2020
Statut:
ppublish
Résumé
Pulmonary hypertension is newly defined as an elevation of the mean pulmonary arterial pressure >20 mmHg and a pulmonary vascular resistance ≥3 Wood units. Arrhythmias are an increasing problem in patients with pulmonary hypertension. Pathophysiological aspects leading to supraventricular arrhythmias are atrial fibrosis caused by increased right atrial pressure and dilation. An increased sympathetic tone leads to prolongation of action potential and delayed polarisations causing arrhythmias. Therapy of arrhythmias includes drugs (preferred amiodarone) and electrophysiological therapy like electric cardioversion and ablation, which is safe in patients with pulmonary hypertension.
Identifiants
pubmed: 32048010
doi: 10.1007/s00399-020-00668-w
pii: 10.1007/s00399-020-00668-w
doi:
Substances chimiques
Amiodarone
N3RQ532IUT
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM
Pagination
33-38Références
J Interv Card Electrophysiol. 2014 Oct;41(1):9-14
pubmed: 25005454
Pulm Circ. 2018 Apr-Jun;8(2):2045894018769874
pubmed: 29575972
Biomed Res Int. 2016;2016:1327265
pubmed: 28090536
Europace. 2011 Dec;13(12):1753-9
pubmed: 21784747
Circulation. 1999 Jan 19;99(2):262-70
pubmed: 9892593
Int J Cardiol. 2018 Dec 1;272S:30-36
pubmed: 30190156
Cardiol J. 2016;23(4):465-72
pubmed: 27367480
Int J Cardiol. 2013 Sep 1;167(5):2300-5
pubmed: 22727973
Biomed Res Int. 2014;2014:617565
pubmed: 24977152
Int J Cardiol. 2011 Jan 7;146(1):105-6
pubmed: 21056484
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30552088
Ann Noninvasive Electrocardiol. 2015 Jan;20(1):69-78
pubmed: 24903540
PLoS One. 2012;7(3):e33902
pubmed: 22439013
Am Heart J. 2007 Jan;153(1):127-32
pubmed: 17174650
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
Pharmacol Ther B. 1975;1(1):115-38
pubmed: 772700
Heart Lung. 2018 May - Jun;47(3):237-242
pubmed: 29454666
Heart Lung. 2014 Nov-Dec;43(6):534-40
pubmed: 24929769
Lung. 2003 Nov-Dec;181(6):321-8
pubmed: 14749936
Eur Heart J. 2020 Feb 1;41(5):655-720
pubmed: 31504425
Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):155-62
pubmed: 26031512
Circ Heart Fail. 2017 Apr;10(4):
pubmed: 28364092
Am J Cardiol. 2015 Dec 15;116(12):1883-9
pubmed: 26522342
Int J Cardiol. 2016 Nov 15;223:860-862
pubmed: 27580221
J Am Coll Cardiol. 2018 Oct 2;72(14):e91-e220
pubmed: 29097296
Am J Physiol Heart Circ Physiol. 2018 Mar 1;314(3):H542-H551
pubmed: 29146614
Circulation. 2006 Sep 5;114(10):e385-484
pubmed: 16935995
Pulm Circ. 2018 Jul-Sep;8(3):2045894018790316
pubmed: 29969045
Int J Cardiol. 2018 Dec 1;272S:46-52
pubmed: 30190155
Front Pediatr. 2015 Jul 07;3:63
pubmed: 26217650
Heart Lung Circ. 2016 May;25(5):442-50
pubmed: 26643289
Int J Cardiol. 2011 Jun 2;149(2):279-280
pubmed: 21420184
J Cardiovasc Electrophysiol. 2012 Nov;23(11):1185-90
pubmed: 22734591
Am J Cardiol. 2014 Nov 1;114(9):1420-5
pubmed: 25217453
Eur J Heart Fail. 2004 Mar 1;6(2):181-5
pubmed: 14984725
Heart Lung Circ. 2012 Nov;21(11):695-9
pubmed: 22795737
Arrhythm Electrophysiol Rev. 2018 Mar;7(1):43-48
pubmed: 29636972